Novo Nordisk Raises 2026 Guidance to a Range of +2% to -2%

Novo Nordisk raised its 2026 adjusted sales and adjusted operating profit guidance to a range of +2% to -2% on November 4, after third-quarter profit beat forecasts, Reuters reported. The range straddles zero. In February, the company forecast a decline of as much as 13%. In May, it said the worst drop would likely be 12%.